Management of Membranous Nephropathy After MENTOR

Clinical Journal of the American Society of Nephrology - United States
doi 10.2215/cjn.10240819
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society of Nephrology (ASN)

Related search

Membranous Nephropathy

2019English

Management of Idiopathic Membranous Nephropathy: Evidence-Based Recommendations

Kidney International
Nephrology
1999English

Cancer Risk After Cyclophosphamide Treatment in Idiopathic Membranous Nephropathy

Clinical Journal of the American Society of Nephrology
EpidemiologyNephrologyCritical CareTransplantationIntensive Care Medicine
2014English

Non-Ischemic Cardiomyopathy After Rituximab Treatment for Membranous Nephropathy

Journal of Renal Injury Prevention
UrologyNephrology
2016English

Membranous Nephropathy: An Update

Portuguese Journal of Nephrology & Hypertension
2019English

Experimental Models of Membranous Nephropathy

Drug Discovery Today: Disease Models
Drug DiscoveryMolecular Medicine
2010English

Variation of Peripheral Th17/Treg Imbalance in Patients With Idiopathic Membranous Nephropathy After Cyclosporin a Treatment: A Prognostic Marker of Idiopathic Membranous Nephropathy

Biomedical Journal of Scientific & Technical Research
2018English

Comparison of Prognostic, Clinical, and Renal Histopathological Characteristics of Overlapping Idiopathic Membranous Nephropathy and IgA Nephropathy Versus Idiopathic Membranous Nephropathy

Scientific Reports
Multidisciplinary
2017English

Membranous Nephropathy With Crescent After Ematopoietic Cell Transplantation: A Case Report

Internal Medicine
Internal MedicineMedicine
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy